| |
Last Name |
First Name |
Research/Clinical Interest Title |
Keywords |
 |
NAHM |
MOON |
Adaptive and Innate Immune Responses to Pneumococci and Pneumonia Vaccines |
pneumococcus, capsule, innate immunity, pathogenesis, vaccines |
 |
NAHM |
MOON |
Adaptive and Innate Immune Responses to Pneumococci and Pneumonia Vaccines |
pneumococcus, capsule, innate immunity, pathogenesis, vaccines |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NAMAKKAL SOORAPPAN |
RAJASEKARAN |
Nrf2/Keap1 dependent mechanisms for reductive stress in heart and brain |
Reductive Stress, Nrf2-Keap1 Signaling, Cardiac Remodeling, Proteotoxicity, Cardiac Aging, Neurodegeneration, Alzheimer's disease |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NIEDERWEIS |
MICHAEL |
Novel proteins in the outer membrane of mycobacteria: Functions, structures, role in tuberculosis and applications |
tuberculosis, virulence, antibiotic resistance, membrane, proteins, transport, nanotechnology |
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
NOVAK |
JAN |
Pathogenesis and treatments of chronic diseases, infectious diseases, cancer. IgA nephropathy. Mucosal immunology. Biomarkers. |
|
 |
OCHSENBAUER |
CHRISTINA |
|
|
 |
ORIHUELA |
CARLOS |
Host-pathogen interactions for development of invasive pneumococcal disease |
Streptococcus pneumoniae, aging, pathogenesis, innate immunology, necroptosis |
 |
ORIHUELA |
CARLOS |
Host-pathogen interactions for development of invasive pneumococcal disease |
Streptococcus pneumoniae, aging, pathogenesis, innate immunology, necroptosis |
 |
ORIHUELA |
CARLOS |
Host-pathogen interactions for development of invasive pneumococcal disease |
Streptococcus pneumoniae, aging, pathogenesis, innate immunology, necroptosis |
 |
ORIHUELA |
CARLOS |
Host-pathogen interactions for development of invasive pneumococcal disease |
Streptococcus pneumoniae, aging, pathogenesis, innate immunology, necroptosis |
 |
ORIHUELA |
CARLOS |
Host-pathogen interactions for development of invasive pneumococcal disease |
Streptococcus pneumoniae, aging, pathogenesis, innate immunology, necroptosis |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
 |
PARANT |
JOHN |
Animal Models of Genomic Instability, p53 Regulation, Cancer and Mitotic Dysfunction |
Zebrafish, Mouse, Li Fraumeni Syndrome, Roberts syndrome, Birth Defects, Tumor Suppressor, Genomic Instability, Aneuploidy, Mitosis, DNA damage, Cancer, and Apoptosis. |
|